137 related articles for article (PubMed ID: 23821412)
1. Formation kinetics and structural features of Beta-amyloid aggregates by sedimented solute NMR.
Bertini I; Gallo G; Korsak M; Luchinat C; Mao J; Ravera E
Chembiochem; 2013 Sep; 14(14):1891-7. PubMed ID: 23821412
[TBL] [Abstract][Full Text] [Related]
2. The molecular structure of Alzheimer β-amyloid fibrils formed in the presence of phospholipid vesicles.
Niu Z; Zhao W; Zhang Z; Xiao F; Tang X; Yang J
Angew Chem Int Ed Engl; 2014 Aug; 53(35):9294-7. PubMed ID: 24810551
[TBL] [Abstract][Full Text] [Related]
3. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
Bokvist M; Lindström F; Watts A; Gröbner G
J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
[TBL] [Abstract][Full Text] [Related]
4. Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers.
Huang D; Zimmerman MI; Martin PK; Nix AJ; Rosenberry TL; Paravastu AK
J Mol Biol; 2015 Jul; 427(13):2319-28. PubMed ID: 25889972
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
[TBL] [Abstract][Full Text] [Related]
6. A new structural model of Aβ40 fibrils.
Bertini I; Gonnelli L; Luchinat C; Mao J; Nesi A
J Am Chem Soc; 2011 Oct; 133(40):16013-22. PubMed ID: 21882806
[TBL] [Abstract][Full Text] [Related]
7. Solution NMR studies of recombinant Aβ(1-42): from the presence of a micellar entity to residual β-sheet structure in the soluble species.
Wälti MA; Orts J; Vögeli B; Campioni S; Riek R
Chembiochem; 2015 Mar; 16(4):659-69. PubMed ID: 25676345
[TBL] [Abstract][Full Text] [Related]
8. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.
Lopez del Amo JM; Fink U; Dasari M; Grelle G; Wanker EE; Bieschke J; Reif B
J Mol Biol; 2012 Aug; 421(4-5):517-24. PubMed ID: 22300765
[TBL] [Abstract][Full Text] [Related]
9. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
Narayanan S; Reif B
Biochemistry; 2005 Feb; 44(5):1444-52. PubMed ID: 15683229
[TBL] [Abstract][Full Text] [Related]
10. Transient formation of intermediate conformational states of amyloid-β peptide revealed by heteronuclear magnetic resonance spectroscopy.
Yamaguchi T; Matsuzaki K; Hoshino M
FEBS Lett; 2011 Apr; 585(7):1097-102. PubMed ID: 21402073
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
[TBL] [Abstract][Full Text] [Related]
12. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.
Petkova AT; Ishii Y; Balbach JJ; Antzutkin ON; Leapman RD; Delaglio F; Tycko R
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16742-7. PubMed ID: 12481027
[TBL] [Abstract][Full Text] [Related]
13. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
Milojevic J; Esposito V; Das R; Melacini G
J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
[TBL] [Abstract][Full Text] [Related]
14. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N; Klementieva O; Cladera J
Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation.
Fawzi NL; Ying J; Torchia DA; Clore GM
J Am Chem Soc; 2010 Jul; 132(29):9948-51. PubMed ID: 20604554
[TBL] [Abstract][Full Text] [Related]
16. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
17. Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides.
Naito A; Kawamura I
Biochim Biophys Acta; 2007 Aug; 1768(8):1900-12. PubMed ID: 17524351
[TBL] [Abstract][Full Text] [Related]
18. Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization.
Ni CL; Shi HP; Yu HM; Chang YC; Chen YR
FASEB J; 2011 Apr; 25(4):1390-401. PubMed ID: 21209058
[TBL] [Abstract][Full Text] [Related]
19. A hexameric peptide barrel as building block of amyloid-β protofibrils.
Lendel C; Bjerring M; Dubnovitsky A; Kelly RT; Filippov A; Antzutkin ON; Nielsen NC; Härd T
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12756-60. PubMed ID: 25256598
[TBL] [Abstract][Full Text] [Related]
20. A routine method for cloning, expressing and purifying Aβ(1-42) for structural NMR studies.
Weber DK; Sani MA; Gehman JD
Amino Acids; 2014 Oct; 46(10):2415-26. PubMed ID: 25027618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
